Cytomx Therapeutics to Announce Third Quarter 2017 Financial Results

On October 26, 2017 CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody therapeutics for the treatment of cancer, reported that it will announce financial results for the third quarter ended September 30, 2017, on November 7, 2017, after the NASDAQ market closing (Press release, CytomX Therapeutics, OCT 26, 2017, View Source [SID1234521211]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The company will not conduct a conference call in conjunction with this financial results press release.

Juniper Pharmaceuticals to Report Third Quarter 2017 Results on November 2, 2017

On October 26, 2017 Juniper Pharmaceuticals (Nasdaq: JNP) (“Juniper” or the “Company”), reported that it will hold a conference call on November 2, 2017, to discuss the financial results for the third quarter ended September 30, 2017, as follows (Press release, Juniper Pharmaceuticals, OCT 26, 2017, View Source [SID1234521214]):

Date:
Thursday, November 2, 2017
Time:
4:30 p.m.
Dial-in numbers:
Toll free: (1-866-374-4635) (U.S.), (1-855-669-9657) (Canada), or

International: (1-412-902-4218)

Audio webcast (live & archive): www.juniperpharma.com, under ‘Investors’ or click here.

The teleconference replay will be available approximately one hour after completion through Thursday, November 9, 2017, at 1-877-344-7529 (U.S.), 1-855-669-9658 (Canada) or 1-412-317-0088 (International). The replay access code is 10113476.

The archived webcast will be available for one year via the aforementioned URLs.

Keryx Biopharmaceuticals to Host Conference Call of Third Quarter 2017 Financial Results on Monday, November 6, 2017

On October 26, 2017 Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, reported that it plans to host a conference call and webcast on Monday, November 6, 2017 at 5:00 p.m. ET to discuss its third quarter 2017 financial results and provide a corporate update (Press release, Keryx Biopharmaceuticals, OCT 26, 2017, View Source [SID1234521215]).

To participate in the conference call, please dial 1-888-396-2320 (U.S.), 1-774-264-7560 (international) and refer to conference ID: 2193619. The call will be webcast live with slides and accessible through the Investors section of the company’s website at www.keryx.com for a period of 15 days after the call.

Puma Biotechnology to Host Conference Call to Discuss Third Quarter Financial Results

On October 26, 2017 Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company reported that it will host a conference call at 1:30 p.m. PST/4:30 p.m. EST on Thursday, November 9, 2017, following release of its third quarter 2017 financial results (Press release, Puma Biotechnology, OCT 26, 2017, http://investor.pumabiotechnology.com/press-release/puma-biotechnology-host-conference-call-discuss-third-quarter-financial-results [SID1234521216]).

The call may be accessed by dialing 1-877-709-8150 (domestic) or 1-201-689-8354 (international). Please dial in at least ten minutes in advance and inform the operator that you would like to join the “Puma Biotechnology Conference Call.” A live webcast of the conference call and presentation slides may be accessed on the Investors section of the Puma Biotechnology website at View Source A replay of the call will be available approximately one hour after completion of the call and will be archived on the company’s website for 90 days.

ZIOPHARM Oncology to Host Third-Quarter 2017 Financial Results and Corporate Update Conference Call on November 6, 2017 at 4:30 p.m. ET

On October 26, 2017 ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company developing new gene and cell-based immunotherapies for cancer, reported that it will host a conference call and webcast slide presentation on Monday, November 6, 2017 at 4:30 p.m. ET to provide a corporate update and discuss financial results for the third quarter ended September 30, 2017 (Press release, Ziopharm, OCT 26, 2017, View Source [SID1234521204]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The call can be accessed by dialing 1-844-309-0618 (U.S. and Canada) or 1-661-378-9465 (international). The passcode for the conference call is 8769629. To access the slides and live webcast or the subsequent archived recording, visit the “Investors & Media” section of the ZIOPHARM website at www.ziopharm.com. The webcast will be recorded and available for replay on the Company’s website for two weeks.